• Explore /
  • Poster
  • / Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside in prevention of oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer patients.

Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside in prevention of oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer patients.

Abstract Poster

Authors

null

Yu-hong Li

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Yu-hong Li , De-Shen Wang , Zhiqiang Wang , Jie-wen Peng , Wei Wang , Fen Feng , Yanhong Deng , Jianwei Zhang , Fenghua Wang , Chao Ren , Feng Wang , Ying Jin , Chuanbo Xie , Qiong Tan , Gong Chen , Rui-hua Xu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02251977

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 674)

DOI

10.1200/JCO.2019.37.4_suppl.674

Abstract #

674

Poster Bd #

M19

Abstract Disclosures

Similar Posters

First Author: Yelena Y. Janjigian

First Author: Axel Grothey

First Author: Thorsten Goetze

First Author: Thorsten Oliver Goetze